85 related articles for article (PubMed ID: 10223762)
41. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
Young Tabusso F; Payet Meza E; Celis Zapata J; Ruiz Figueroa E; Berrospi Espinoza F
Rev Gastroenterol Peru; 2002; 22(3):213-20. PubMed ID: 12378215
[TBL] [Abstract][Full Text] [Related]
42. Are survival rates different for young and older patients with rectal cancer?
O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
[TBL] [Abstract][Full Text] [Related]
43. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
44. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
45. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
[TBL] [Abstract][Full Text] [Related]
46. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
47. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
48. Correlation of nuclear morphometry and DNA ploidy in rectal cancer.
Heimann TM; Cohen RD; Szporn A; Gil J
Dis Colon Rectum; 1991 Jun; 34(6):449-54. PubMed ID: 2036923
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of prognostic factors of rectal cancer in the elderly].
Liang H; Hao XS; Wang XN; Li JW; Wang JC; Wang DC
Ai Zheng; 2004 Mar; 23(3):299-302. PubMed ID: 15025962
[TBL] [Abstract][Full Text] [Related]
50. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
51. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
[TBL] [Abstract][Full Text] [Related]
52. Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer.
Jullumstrø E; Lydersen S; Møller B; Dahl O; Edna TH
Eur J Cancer; 2009 Sep; 45(13):2383-90. PubMed ID: 19356923
[TBL] [Abstract][Full Text] [Related]
53. The importance of histopathological and clinical variables in predicting the evolution of colon cancer.
Diculescu M; Iacob R; Iacob S; Croitoru A; Becheanu G; Popeneciu V
Rom J Gastroenterol; 2002 Sep; 11(3):183-9. PubMed ID: 12368937
[TBL] [Abstract][Full Text] [Related]
54. Morphometric analysis of colorectal cancer.
Deans GT; Hamilton PW; Watt PC; Heatley M; Williamson K; Patterson CC; Rowlands BJ; Parks G; Spence R
Dis Colon Rectum; 1993 May; 36(5):450-6. PubMed ID: 8482164
[TBL] [Abstract][Full Text] [Related]
55. A survival regression analysis of prognostic factors in colorectal cancer.
D'Eredita G; Serio G; Neri V; Polizzi RA; Barberio G; Losacco T
Aust N Z J Surg; 1996 Jul; 66(7):445-51. PubMed ID: 8678873
[TBL] [Abstract][Full Text] [Related]
56. Classification of normal colorectal mucosa and adenocarcinoma by morphometry.
Hamilton PW; Allen DC; Watt PC; Patterson CC; Biggart JD
Histopathology; 1987 Sep; 11(9):901-11. PubMed ID: 3666675
[TBL] [Abstract][Full Text] [Related]
57. Nuclear shape as a prognostic discriminant in colorectal carcinoma.
Mitmaker B; Begin LR; Gordon PH
Dis Colon Rectum; 1991 Mar; 34(3):249-59. PubMed ID: 1999132
[TBL] [Abstract][Full Text] [Related]
58. Temporal morphologic changes in human colorectal carcinomas following xenografting.
Barkla DH; Tutton PJ
Am J Pathol; 1983 Mar; 110(3):315-21. PubMed ID: 6829710
[TBL] [Abstract][Full Text] [Related]
59. Karyometric features in nuclei near colonic adenocarcinoma. Statistical analysis.
Montag AG; Bartels PH; Dytch HE; Lerma-Puertas E; Michelassi F; Bibbo M
Anal Quant Cytol Histol; 1991 Jun; 13(3):159-67. PubMed ID: 1716896
[TBL] [Abstract][Full Text] [Related]
60. The nuclear aberration index assay as a marker for colonic carcinogen exposure.
Glickman LT; Senterman MK; Fleiszer DM
Curr Surg; 1986; 43(5):410-3. PubMed ID: 3769544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
